Zoli, Marco

Metformin in non-alcoholic steatohepatitis.

Marchesini, G., Bianchi, G., Tomassetti, S., Zoli, M., & Melchionda, N. (2001) · The Lancet

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 682

Aging and the Burden of Multimorbidity: Associations With Inflammatory and Anabolic Hormonal Biomarkers

Fabbri, E., An, Y., Zoli, M., Simonsick, E. M., Guralnik, J. M., Bandinelli, S., Boyd, C. M., & Ferrucci, L. (2015) · The Journals of Gerontology: Series A

Chronic Disease Management StrategiesNutrition and Health in Aging

Cited by 240

Psychological status and depression in patients with liver cirrhosis

Bianchi, G., Marchesini, G., Nicolino, F., Graziani, R., Sgarbi, D., Loguercio, C., Abbiati, R., & Zoli, M. (2005) · Digestive and Liver Disease

Liver Disease and TransplantationLiver Diseases and Immunity

Cited by 187

Association Between Accelerated Multimorbidity and Age‐Related Cognitive Decline in Older Baltimore Longitudinal Study of Aging Participants without Dementia

Fabbri, E., An, Y., Zoli, M., Tanaka, T., Simonsick, E. M., Kitner‐Triolo, M. H., Studenski, S. A., Resnick, S. M., & Ferrucci, L. (2016) · Journal of the American Geriatrics Society

Dementia and Cognitive Impairment ResearchChronic Disease Management Strategies

Cited by 123

Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma

Cabibbo, G., Petta, S., Barbara, M., Attardo, S., Bucci, L., Farinati, F., Giannini, E. G., Negrini, G., Ciccarese, F., Rapaccini, G. L., et al. (2017) · Journal of Hepatology

Hepatocellular Carcinoma Treatment and PrognosisHepatitis C virus research

Cited by 110

Anticatabolic Effect of Branched–Chain Amino Acid–Enriched Solutions in Patients With Liver Cirrhosis

Marchesini, G., Zoli, M., Dondi, C., Bianchi, G., Cirulli, M., & Pisi, E. (1982) · Hepatology

Clinical Nutrition and GastroenterologyLiver Disease and Transplantation

Cited by 99

Insulin Resistance Is Associated With Reduced Mitochondrial Oxidative Capacity Measured by 31P-Magnetic Resonance Spectroscopy in Participants Without Diabetes From the Baltimore Longitudinal Study of Aging

Fabbri, E., Chia, C. W., Spencer, R. G., Fishbein, K. W., Reiter, D. A., Cameron, D., Zane, A. C., Moore, Z. A., Gonzalez-Freire, M., Zoli, M., et al. (2017) · Diabetes

Mitochondrial Function and PathologyDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 76

Prognostic impact of diabetes and prediabetes on survival outcomes in patients with chronic heart failure: a post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial

Dauriz, M., Targher, G., Temporelli, P. L., Lucci, D., Gonzini, L., Nicolosi, G. L., Marchioli, R., Tognoni, G., Latini, R., Cosmi, F., et al. (2017) · Journal of the American Heart Association

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 70

Physical activity is negatively associated with the metabolic syndrome in the elderly

Bianchi, G., Rossi, V., Muscari, A., Magalotti, D., Zoli, M., & the Pianoro Study Group (2008) · QJM

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 55